Continued administration of GM1 ganglioside is required to maintain recovery from neuroleptic-induced sensorimotor deficits in MPTP-treated mice
- 1 January 1989
- journal article
- research article
- Published by Elsevier in Life Sciences
- Vol. 45 (25), 2495-2502
- https://doi.org/10.1016/0024-3205(89)90017-9
Abstract
No abstract availableThis publication has 26 references indexed in Scilit:
- Neural plasticity of basal forebrain cholinergic neurons: effects of gangliosidesNeuroscience Letters, 1987
- Parenterally administered GM1 ganglioside prevents retrograde degeneration of cholinergic cells of the rat basal forebrainBrain Research, 1986
- Retrograde changes in the nucleus basalis of the rat, caused by cortical damage, are prevented by exogenous ganglioside GM1Brain Research, 1986
- Effects of ganglioside treatment in rats with a lesion of the cholinergic forebrain nucleiBrain Research, 1985
- GM1 ganglioside enhances regrowth of noradrenaline nerve terminals in rat cerebral cortex lesioned by the neurotoxin 6-hydroxydopamineNeuroscience, 1984
- Effect of GM1 ganglioside on neonatally neurotoxin induced degeneration of serotonin neurons in the rat brainDevelopmental Brain Research, 1984
- Effects of GM1 ganglioside on developing and mature serotonin and noradrenaline neurons lesioned by selective neurotoxinsJournal of Neuroscience Research, 1984
- GM1 ganglioside facilitates the recovery of high‐affinity choline uptake in the cerebral cortex of rats with a lesion of the nucleus basalis magnocellularisJournal of Neuroscience Research, 1984
- Biology of gangliosides: Neuritogenic and neuronotrophic propertiesJournal of Neuroscience Research, 1984
- The stimulating effect of ganglioside injections on the recovery of choline acetyltransferase and acetylcholinesterase activities in the hippocampus of the rat after septal lesionsNeuroscience, 1982